Our News

2025.08.01

Targeted Protein Degradation: From Ubiquitin to your Toolbox for VAV1 Degraders

Precedo Inc. provides in vitro biological evaluation of VAV1 degraders and in vivo assessment using autoimmune disease models, combined with DMPK studies to comprehensively evaluate their degradation properties and ADME characteristics.

Targeted Protein Degradation: From Ubiquitin to your Toolbox for VAV1 Degraders
< 1 > proceed page

Get our latest updates straight to your inbox

Sign Up
%{tishi_zhanwei}%
©2025 Precedo Inc.

Powered by：www.300.cn  hefei   SEO

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.